US Patent 7658939 Tamper-resistant oral opioid agonist formulations
Patent 7658939 was granted and assigned to Purdue Pharma on February, 2010 by the United States Patent and Trademark Office.
All edits
Edits on 30 Oct, 2023
Golden AI
Edits made to:
Article (+221 characters)
Article
Patent abstract
Disclosed is an oral dosage form comprising (i) an opioid agonist in releasable form and (ii) a sequestered opioid antagonist which is substantially not released when the dosage form is administered intact.
Edits on 18 Sep, 2023
Golden AI
Edits made to:
Infobox (+3 properties)
Infobox
Patent Inventor Names
Benjamin Oshlack0
Curtis Wright0
J. David Haddox0
Edits on 24 May, 2023
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Edits on 21 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 18 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07658939 Tamper-resistant oral opioid agonist formulations US Patent 7658939 Tamper-resistant oral opioid agonist formulations
Infobox
Patent Number
076589390
Patent Number
76589390
Edits on 30 Mar, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
076589390
Date of Patent
February 9, 2010
0Patent Application Number
107010410
Date Filed
November 4, 2003
0Official Website
Patent Primary Examiner
Edits on 18 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 3 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07658939 Tamper-resistant oral opioid agonist formulations
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07658939
Date of patent
February 9, 2010
Patent application number
10701041
Date Filed
November 4, 2003
Patent primary examiner
Find more entities like US Patent 7658939 Tamper-resistant oral opioid agonist formulations
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.